Antidepressants and the FDA's black-box warning: determining a rational public policy in the absence of sufficient evidence

Virtual Mentor. 2012 Jun 1;14(6):483-8. doi: 10.1001/virtualmentor.2012.14.6.pfor2-1206.
No abstract available

MeSH terms

  • Adolescent
  • Antidepressive Agents / adverse effects*
  • Antidepressive Agents / therapeutic use
  • Depressive Disorder, Major / drug therapy
  • Humans
  • Risk Assessment
  • Serotonin Uptake Inhibitors / adverse effects
  • Serotonin Uptake Inhibitors / therapeutic use
  • Suicidal Ideation
  • United Kingdom
  • United States
  • United States Food and Drug Administration*

Substances

  • Antidepressive Agents
  • Serotonin Uptake Inhibitors